Skip to main content
    E

    Edgewise Therapeutics Inc (EWTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $43.68
    -2.25 (-4.90%)

    Market Cap: $5.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Edgewise Therapeutics Inc (EWTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Edgewise Therapeutics are Viridian Therapeutics (VRDN), Dyne Therapeutics (DYN) and Cogent Biosciences (COGT). By market cap, Edgewise Therapeutics ranks 5th of the 13 companies on this page; TG Therapeutics (TGTX) is the largest at $9.75B.

    Peer Comparison

    EWTX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Edgewise Therapeutics (EWTX)$5.03BN/AN/A0.0%N/A0.0%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Dyne Therapeutics Inc (DYN)$3.22BN/AN/A0.0%-42.9%0.0%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Viking Therapeutics Inc (VKTX)$3.73BN/AN/A0.0%-61.0%0.0%0.00%
    Disc Medicine Inc. (IRON)$3.64BN/AN/A0.0%-40.0%0.0%0.00%
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Dianthus Therapeutics Inc. (DNTH)$5.17BN/AN/A0.0%N/A205.6%0.00%
    Scholar Rock Holding Corp (SRRK)$5.27BN/AN/A0.0%-89.0%-100.0%0.00%
    Erasca Inc (ERAS)$5.50BN/AN/A0.0%N/A0.0%0.00%
    Peer median$3.91B176.8x15.0x0.0%-41.8%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Edgewise Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Dyne Therapeutics Inc (DYN)
    Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases...
    DYN competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Viking Therapeutics Inc (VKTX)
    Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders.
    VKTX competitors
    Disc Medicine Inc. (IRON)
    Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development...
    IRON competitors
    Crispr Therapeutics AG (CRSP)
    CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.
    CRSP competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Dianthus Therapeutics Inc. (DNTH)
    Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops...
    DNTH competitors
    Scholar Rock Holding Corp (SRRK)
    Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious...
    SRRK competitors
    Erasca Inc (ERAS)
    Erasca Inc. is a pioneering biopharmaceutical firm specializing in the development of targeted therapies for genetically defined cancers...
    ERAS competitors

    Frequently Asked Questions About EWTX

    Who are Edgewise Therapeutics' main competitors?

    The companies most similar to Edgewise Therapeutics include Viridian Therapeutics (VRDN), Dyne Therapeutics (DYN), Cogent Biosciences (COGT), TG Therapeutics (TGTX) and Viking Therapeutics (VKTX), listed from the closest match.

    Who is Edgewise Therapeutics' biggest competitor?

    TG Therapeutics (TGTX) is the largest of the similar companies at $9.75B; Viridian Therapeutics (VRDN) is the closest match by business profile, size, sector and industry.

    How does EWTX stock compare with its competitors?

    EWTX's net margin is 0.0% against a peer median of 0.0%.

    Which of Edgewise Therapeutics' competitors pays a higher dividend?

    Edgewise Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Edgewise Therapeutics bigger than its competitors?

    No. Edgewise Therapeutics is 5th by market cap among the 13 companies on this page; the largest is TG Therapeutics (TGTX) at $9.75B.